Claudia Fromond

Claudia Fromond has more than 20 years’ experience in pharmacology and translational science. She has successfully overseen first-in-class programs from discovery to Investigational New Drug (IND) application and early clinical development, including a portfolio of seven IND-enabling programs which achieved Phase 1/2 readiness.

Claudia Fromond holds a PhD in Cellular and Molecular Biology from the Institut Pasteur, Paris, and the Oswaldo Cruz Foundation, Rio de Janeiro.

She has held a number of senior R&D roles, including Head of Translational Research and Clinical Biomarkers at Advesya, Director of Preclinical and Translational Medicine at OSE Immunotherapeutics, Director Pharmacology at Ablynx-Sanofi, and Head of Biology and Pharmacology at Inventiva Pharma.

She has published published over 30 peer-reviewed articles in international scientific journals and is co-inventor in 4 families of patents.